Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites
NCT01082341Phase 2Completed
- Sponsor
- Malaria Vaccine and Drug Development Center
- Start
- Jun 2012
- Primary completion
- May 2015
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 2 trial of Plasmodium vivax irradiated sporozoites in malaria (3 arms), sponsored by Malaria Vaccine and Drug Development Center. Primary endpoint: Protective Efficacy of P. vivax irradiated sporozoite vaccination at 2 years. Started Jun 2012; status: completed.
02
Drugs
Plasmodium vivax irradiated sporozoites
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01082341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01082341.